144 related articles for article (PubMed ID: 1419619)
41. The most reliable early predictors of outcome in patients with biliary atresia after Kasai's operation.
Goda T; Kawahara H; Kubota A; Hirano K; Umeda S; Tani G; Ishii T; Tazuke Y; Yoneda A; Etani Y; Ida S
J Pediatr Surg; 2013 Dec; 48(12):2373-7. PubMed ID: 24314173
[TBL] [Abstract][Full Text] [Related]
42. Liver function tests in adults with Plasmodium falciparum infection.
Davies MP; Brook GM; Weir WR; Bannister B; Tibbs C
Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):873-5. PubMed ID: 8889453
[TBL] [Abstract][Full Text] [Related]
43. Michaelis-Menten constant of serum aspartate amino transferase (AST) in heart and liver diseases.
Ramakrishnan S; Helen PL; Rajiswamy
Am J Med Technol; 1978 Jul; 44(7):685-7. PubMed ID: 677161
[TBL] [Abstract][Full Text] [Related]
44. The liver function profile in PCR-RNA Egyptian HCV-patients and normal controls.
Wahib AA; Seif El Nasr MS; Mangoud AM; El Shazly AM; Morsy AT
J Egypt Soc Parasitol; 2005 Aug; 35(2):451-66. PubMed ID: 16083059
[TBL] [Abstract][Full Text] [Related]
45. Dose-adjusting epirubicin in patients with altered liver function: when classical pharmacology makes good practical sense.
Gianni L
Eur J Cancer; 2003 Mar; 39(5):557-9. PubMed ID: 12628833
[No Abstract] [Full Text] [Related]
46. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy.
Rühl R; Seidensticker M; Peters N; Mohnike K; Bornschein J; Schütte K; Amthauer H; Malfertheiner P; Pech M; Ricke J
Dig Dis; 2009; 27(2):189-99. PubMed ID: 19546558
[TBL] [Abstract][Full Text] [Related]
47. Impairment of drug metabolism in patients with liver cancer.
Sotaniemi EA; Pelkonen RO; Mokka RE; Huttunen R; Viljakainen E
Eur J Clin Invest; 1977 Aug; 7(4):269-74. PubMed ID: 196861
[No Abstract] [Full Text] [Related]
48. [Magnesium isoglycyrrhizinate prevention of chemotherapy-induced liver damage during initial treatment of patients with gastrointestinal tumors].
Yan Y; Mo Y; Zhang D
Zhonghua Gan Zang Bing Za Zhi; 2015 Mar; 23(3):204-8. PubMed ID: 25938834
[TBL] [Abstract][Full Text] [Related]
49. Epirubicin plasma and blood pharmacokinetics after single i.v. bolus in advanced cancer patients.
Camaggi CM; Strocchi E; Martoni A; Angelelli B; Comparsi R; Pannuti F
Drugs Exp Clin Res; 1985; 11(4):285-94. PubMed ID: 3869807
[TBL] [Abstract][Full Text] [Related]
50. A prospective study of the causes of notably raised aspartate aminotransferase of liver origin.
Whitehead MW; Hawkes ND; Hainsworth I; Kingham JG
Gut; 1999 Jul; 45(1):129-33. PubMed ID: 10369716
[TBL] [Abstract][Full Text] [Related]
51. Variability in the pharmacokinetics of epirubicin: a population analysis.
Wade JR; Kelman AW; Kerr DJ; Robert J; Whiting B
Cancer Chemother Pharmacol; 1992; 29(5):391-5. PubMed ID: 1551178
[TBL] [Abstract][Full Text] [Related]
52. Liver Function Indicators Performed Better to Eliminate Cardioembolic Stroke than to Identify It from Stroke Subtypes.
Tan G; Yuan R; Hao Z; Lei C; Xiong Y; Xu M; Liu M
J Stroke Cerebrovasc Dis; 2017 Jan; 26(1):230-236. PubMed ID: 27789152
[TBL] [Abstract][Full Text] [Related]
53. [Ultrasonic scores combined with blood indexes for screening and predicting compensated liver cirrhosis in chronic hepatitis B patients].
Chen YP; Hou JL; Dai L; Wang JL; Zhu YF
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2157-60. PubMed ID: 19114345
[TBL] [Abstract][Full Text] [Related]
54. Dose-escalating and pharmacologic study of oxaliplatin in adult cancer patients with impaired hepatic function: a National Cancer Institute Organ Dysfunction Working Group study.
Synold TW; Takimoto CH; Doroshow JH; Gandara D; Mani S; Remick SC; Mulkerin DL; Hamilton A; Sharma S; Ramanathan RK; Lenz HJ; Graham M; Longmate J; Kaufman BM; Ivy P;
Clin Cancer Res; 2007 Jun; 13(12):3660-6. PubMed ID: 17575231
[TBL] [Abstract][Full Text] [Related]
55. Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysis.
Nguyen-Khac E; Thiele M; Voican C; Nahon P; Moreno C; Boursier J; Mueller S; de Ledinghen V; Stärkel P; Gyune Kim S; Fernandez M; Madsen B; Naveau S; Krag A; Perlemuter G; Ziol M; Chatelain D; Diouf M
Lancet Gastroenterol Hepatol; 2018 Sep; 3(9):614-625. PubMed ID: 29983372
[TBL] [Abstract][Full Text] [Related]
56. Liver morphology and biochemistry in eight obese patients treated with jejunoileal anastomosis.
Juhl E; Christoffersen P; Baden H; Quaade F
N Engl J Med; 1971 Sep; 285(10):543-7. PubMed ID: 4104638
[No Abstract] [Full Text] [Related]
57. Effect of acute hepatic failure on epirubicin pharmacokinetics after intrahepatic arterial injection in rats.
Nagata M; Matsuo Y; Hidaka M; Kawano Y; Okumura M; Tokunaga J; Takamura N; Arimori K
Biol Pharm Bull; 2008 Mar; 31(3):493-6. PubMed ID: 18310916
[TBL] [Abstract][Full Text] [Related]
58. Assessment of the validity of a population pharmacokinetic model for epirubicin.
Ralph LD; Sandstrom M; Twelves C; Dobbs NA; Thomson AH
Br J Clin Pharmacol; 2006 Jul; 62(1):47-55. PubMed ID: 16842378
[TBL] [Abstract][Full Text] [Related]
59. Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients.
Danesi R; Innocenti F; Fogli S; Gennari A; Baldini E; Di Paolo A; Salvadori B; Bocci G; Conte PF; Del Tacca M
Br J Clin Pharmacol; 2002 May; 53(5):508-18. PubMed ID: 11994057
[TBL] [Abstract][Full Text] [Related]
60. An analysis of imaging studies and liver function tests to detect hepatic neoplasia.
McGarrity TJ; Samuels T; Wilson FA
Dig Dis Sci; 1987 Oct; 32(10):1113-7. PubMed ID: 3308375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
